Myrtelle is a gene therapy company that offers clinical trials for the treatment of rare monogenetic disorders. It helps in addressing an array of diseases with white matter involvement that includes demyelinating diseases and ASPA-associated disorders with rare CNS diseases. It also helps healthcare professionals to develop and deliver noveltreatments for devastating disorders of the central nervous system and transform the treatment of neurological diseases that improve the quality of life and longevity.The company's mission is to develop and deliver novel treatments for devastating disorders of the central nervous system, beginning with its lead program, gene therapy treatment for Canavan disease.It was founded in 2020 and is headquartered in Wakefield, Massachusetts.

Biotechnology

Health Care

Myrtelle

Jordana Holovach

Olga Flamini (Borodovitsyna), MD, PhD

Thomas Madore, CPA, MBA, MSA

Michelle Hylan

This department oversees technical processes and external manufacturing relationships to ensure efficient operations.

Technical Operations

This department oversees clinical operations and strategic medical initiatives to ensure high-quality patient care.

Myrtelle

Org chart

Teams

Technical Operations

Clinical Leadership

Offices

Myrtelle

Org chart

Teams

Technical Operations

Clinical Leadership

Offices

Related companies